Breast cancer survivors can lose weight through modest lifestyle changes
the ONA take:
Female breast cancer survivors may be able to lose weight through modest lifestyle changes, according to a recent study presented at the American Society of Clinical Oncology (ASCO) 2015 meeting in Chicago.
Tim Byers, MD, MPH, of the University of Colorado Cancer Center and fellow researchers looked at 700 women at four sites around the U.S. for two years as part of a randomized control trial in which half of the participants underwent lifestyle interventions.
“The goal was to lose seven percent of their body weight and maintain it for two years,” said study collaborator Rebecca Sedjo, PhD. The women in the intervention group attended motivational meetings which focused on increasing physical activity and decreasing caloric intake.
Within the first 12 months, average weight loss among the participants in the intervention group was six percent of total body weight.
“This is a significant finding because it shows that women are able to lose weight after breast cancer treatment and this may lead to reduced risk of recurrence,” said Dr. Byers.
Female breast cancer survivors may be able to lose weight through modest lifestyle changes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|